A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) C07D 211/18 (2006.01) C07D 211/24 (2006.01) C07D 211/26 (2006.01) C07D 211/28 (2006.01) C07D 211/34 (2006.01) C07D 211/58 (2006.01) C07D 211/66 (2006.01) C07D 211/76 (2006.01) C07D 401/04 (2006.01) C07D 401/10 (2006.01) C07D 401/14 (2006.01) C07D 417/04 (2006.01)
Patent
CA 2344807
A compound having formula (Ia) and any pharmaceutically-acceptable salt thereof, and their use for treating depression, anxiety, asthma, rheumatoid arthritis, Alzheimer's disease, cancer, schizophrenia, oedema, allergic rhinitis, inflammation, pain, gastrointestinal-hypermotility, anxiety, emesis, Huntington's disease, psychoses including depression, hypertension, migraine, bladder hypermotility, or urticaria and compositions including such compounds and processes for making the compounds.
L'invention se rapporte à un composé représenté par la formule (Ia), à tout sel pharmaceutiquement acceptable de ce composé ainsi qu'à leur utilisation pour traiter la dépression, l'anxiété, l'asthme, la polyarthrite rhumatoïde, la maladie d'Alzheimer, le cancer, la schizophrénie, les oedèmes, la rhinite allergique, les inflammations, la douleur, l'hypermotilité gastro-intestinale, l'anxiété, les vomissements, la chorée de Huntington, les psychoses du type dépression, hypertension, migraine, hypermotilité de la vessie, ou l'urticaire. L'invention se rapporte également à des compositions pharmaceutiques contenant ces composés et à des procédés de fabrication de ces composés.
Bernstein Peter Robert
Dedinas Robert Frank
Ohnmacht Cyrus John
Russell Keith
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Naphthalenecarboxamides as tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalenecarboxamides as tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalenecarboxamides as tachykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1539699